402 related articles for article (PubMed ID: 17952765)
1. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin.
Xu Y; Choi J; Hylander B; Sen A; Evans SS; Kraybill WG; Repasky EA
Int J Hyperthermia; 2007 Sep; 23(6):513-27. PubMed ID: 17952765
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia and liposomal encapsulated doxorubicin.
Ben-Yosef R; Gipps M; Zeira M
Isr Med Assoc J; 2003 Jun; 5(6):407-9. PubMed ID: 12841010
[TBL] [Abstract][Full Text] [Related]
3. A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models.
Kraybill WG; Olenki T; Evans SS; Ostberg JR; O'Leary KA; Gibbs JF; Repasky EA
Int J Hyperthermia; 2002; 18(3):253-66. PubMed ID: 12028640
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer.
Hattori T; Kokura S; Okuda T; Okayama T; Takagi T; Handa O; Naito Y; Yoshida N; Yoshikawa T
Int J Hyperthermia; 2007 Nov; 23(7):591-8. PubMed ID: 18038289
[TBL] [Abstract][Full Text] [Related]
5. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D
Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126
[TBL] [Abstract][Full Text] [Related]
6. A tracer dose of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasation.
Kleiter MM; Yu D; Mohammadian LA; Niehaus N; Spasojevic I; Sanders L; Viglianti BL; Yarmolenko PS; Hauck M; Petry NA; Wong TZ; Dewhirst MW; Thrall DE
Clin Cancer Res; 2006 Nov; 12(22):6800-7. PubMed ID: 17121901
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of doxorubicin thermosensitive liposomes (40 degrees C) and local hyperthermia on rat rhabdomyosarcoma.
Morita K; Zywietz F; Kakinuma K; Tanaka R; Katoh M
Oncol Rep; 2008 Aug; 20(2):365-72. PubMed ID: 18636199
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.
Ahmed M; Monsky WE; Girnun G; Lukyanov A; D'Ippolito G; Kruskal JB; Stuart KE; Torchilin VP; Goldberg SN
Cancer Res; 2003 Oct; 63(19):6327-33. PubMed ID: 14559820
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia.
Burd R; Dziedzic TS; Xu Y; Caligiuri MA; Subjeck JR; Repasky EA
J Cell Physiol; 1998 Oct; 177(1):137-47. PubMed ID: 9731754
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin.
Pastorino F; Di Paolo D; Piccardi F; Nico B; Ribatti D; Daga A; Baio G; Neumaier CE; Brignole C; Loi M; Marimpietri D; Pagnan G; Cilli M; Lepekhin EA; Garde SV; Longhi R; Corti A; Allen TM; Wu JJ; Ponzoni M
Clin Cancer Res; 2008 Nov; 14(22):7320-9. PubMed ID: 19010847
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three approaches to doxorubicin therapy: free doxorubicin, liposomal doxorubicin, and beta-glucuronidase-activated prodrug (HMR 1826).
Woessner R; An Z; Li X; Hoffman RM; Dix R; Bitonti A
Anticancer Res; 2000; 20(4):2289-96. PubMed ID: 10953287
[TBL] [Abstract][Full Text] [Related]
13. Effect of whole-body hyperthermia on cell survival, metastasis frequency, and host immunity in moderately and weakly immunogenic murine tumors.
Urano M; Rice L; Epstein R; Suit HD; Chu AM
Cancer Res; 1983 Mar; 43(3):1039-43. PubMed ID: 6825078
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia.
Baba H; Stephens LC; Strebel FR; Siddik ZH; Newman RA; Ohno S; Bull JM
Cancer Res; 1991 Jul; 51(13):3568-77. PubMed ID: 1905199
[TBL] [Abstract][Full Text] [Related]
15. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure.
Frenkel V; Etherington A; Greene M; Quijano J; Xie J; Hunter F; Dromi S; Li KC
Acad Radiol; 2006 Apr; 13(4):469-79. PubMed ID: 16554227
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of kigamicin D on mouse tumor models.
Masuda T; Ohba S; Kawada M; Osono M; Ikeda D; Esumi H; Kunimoto S
J Antibiot (Tokyo); 2006 Apr; 59(4):209-14. PubMed ID: 16830887
[TBL] [Abstract][Full Text] [Related]
17. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.
Baba H; Siddik ZH; Strebel FR; Jenkins GN; Bull JM
Cancer Res; 1989 Dec; 49(24 Pt 1):7041-4. PubMed ID: 2582445
[TBL] [Abstract][Full Text] [Related]
18. Characterization of mild whole-body hyperthermia protocols using human breast, ovarian, and colon tumors grown in severe combined immunodeficient mice.
Repasky EA; Tims E; Pritchard M; Burd R
Infect Dis Obstet Gynecol; 1999; 7(1-2):91-7. PubMed ID: 10231015
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy: a means to enhanced drug delivery to tumors.
Snyder JW; Greco WR; Bellnier DA; Vaughan L; Henderson BW
Cancer Res; 2003 Dec; 63(23):8126-31. PubMed ID: 14678965
[TBL] [Abstract][Full Text] [Related]
20. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]